Bradmer Pharmaceuticals Inc. Announces Grant of Options to Directors and Officers

Dow Jones

38,589.16

Get Started

Home
Investing
Stocks
Canada
TSXV
Bradmer Pharmaceuticals (BMR.H)
Bradmer Pharmaceuticals (BMR.H) News

Share Name	Share Symbol	Market	Type
Bradmer Pharmaceuticals	TSXV:BMR.H	TSX Venture	Ordinary Share

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%							0.00	-

Bradmer Pharmaceuticals Inc. Announces Grant of Options to Directors and Officers

21/07/2011 9:05pm

Marketwired

Bradmer Pharmaceuticals (TSXV:BMR.H)
Historical Stock Chart

From Jun 2019 to Jun 2024

Click Here for more Bradmer Pharmaceuticals Charts.

Bradmer Pharmaceuticals Inc. (TSX VENTURE: BMR.H) announced today that it has granted, subject to regulatory approval, options to directors and officers of the company exercisable to acquire an aggregate of 1,500,000 common shares, at a price of $0.10 per share, expiring July 21, 2021.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Contacts: Bradmer Pharmaceuticals Inc. Paul Van Damme 416.987.6113 pvandamme@bradmerpharma.com